AbBaltis

AbBaltis

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

AbBaltis operates as a specialized supplier of biologically-based products, primarily disease state plasma and clinical samples, to the global IVD and biotech research sectors. The company leverages its expertise in sample procurement, processing, and protein purification to offer reliable, high-quality materials with a focus on fast global delivery and competitive pricing. Led by a founder with deep industry experience, AbBaltis has established itself as an award-winning service provider, recognized for its international trade achievements. Its business model is centered on providing essential research tools and services, positioning it as an enabler for diagnostic innovation rather than a developer of its own diagnostic tests.

AntibodiesDiagnostics

Technology Platform

Specialized biobanking, plasma processing, and protein purification services for human biological samples.

Opportunities

The growing global IVD market and increasing demand for biomarker validation create sustained need for high-quality clinical samples.
Expansion into new geographic markets and offering more value-added services like advanced sample characterization present significant growth avenues.

Risk Factors

Operational risks include dependency on a complex, regulated supply chain for human samples and vulnerability to global shipping disruptions.
The business is also subject to cyclical R&D spending from biotech and diagnostic clients and faces competition from other sample suppliers.

Competitive Landscape

AbBaltis competes with other biobanks, plasma suppliers, and clinical research organizations that provide human biological samples for research. Differentiation is achieved through a focused product catalog, specialized processing services, fast global logistics, and a strong customer service ethos.